期刊
SCIENCE
卷 327, 期 5971, 页码 1345-1350出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1177319
关键词
-
资金
- JST
- Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20370084, 21770226]
- New Energy and Technology Development Organization
- Grants-in-Aid for Scientific Research [20370084, 21770226] Funding Source: KAKEN
Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据